Share Prices & Company Research

Stockbroking

Abzena

Current Price 9.89p Bid 9.50p Ask 10.00p Change -2.50%
Last Updated: 22/06/2018 20:06. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Abzena plc provides proprietary technologies and complementary services to enable the development and manufacture of biopharmaceutical products. The term 'Abzena inside' is used by Abzena to describe products that have been created using its proprietary technologies and are being developed by its partners, and include Composite Human Antibodies and ThioBridge Antibody Drug Conjugates (ADCs). Abzena has the potential to earn future licence fees, milestone payments and/or royalties on 'Abzena inside' products.

Financial Highlights Year Ended 31/03/2018

Turnover
£21.95m
Operating Profit
£-14.94m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-1.43

Key Personnel

Dr William John Edward Burt
Chief Executive Officer
Julian Matthew Smith
Chief Financial Officer
Dr Kenneth Thomas Cunningham
Executive Chairman
Anthony David Brampton
Non-Executive Director
Peter William Grant
Non-Executive Director
Dr Nigel Aaron Pitchford
Non-Executive Director
Dr Ingrid Charlotta Ljungqvist
Non-Executive Director

Stock Details

EPIC
ABZA
ISIN
GB00BN65QN46
Shares in Issue
214,220,399
Market cap
£21.42m

Analyst Views (2)

Strong Buy
 
100.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
9.75p
Bid Price
9.50p
Ask Price
10.00p
Volume
399748
Change Today
-0.25p
% Change Today
-2.50%
Open
9.89p
Previous Close
9.75p
Intraday High
9.98p
Intraday Low
9.50p
52 Week High
54.50p
52 Week Low
10.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Abzena Intra-day Chart

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Tangible Assets
11.5
7.6
Intangible Assets & Goodwill
23.1
25.9
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
34.7
33.5
Inventory
1.9
1.9
Trade & Receivables
10.2
5.0
Cash & Receivables
6.8
4.1
Other Current Assets & Assets Held for Resale
0.8
0.3
Total Assets
54.3
44.8

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Short Term Liabilities
6.9
6.3
Long Term Liabilities
3.7
2.5
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
10.6
8.8

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Net Assets
43.7
35.9

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Share Capital
0.4
0.3
Minority Interests
0.0
0.0
Retained Earnings
-24.3
-10.2
Share Premium Account
65.6
41.8
Other Equity
2.0
4.0
Total Equity
43.7
35.9

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Cashflow from Operating Activities
-14.9
-6.2
Cashflow Before Financing
-21.0
-9.5
Increase / Decrease in Cash
2.7
-9.6

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Mar 2018
31 Mar 2017
Turnover
22.0
18.7
Cost of Sales
12.3
10.6
Gross Profit
9.6
8.1
Operating Profit
-14.9
-9.7
Pre-Tax Profit
-14.8
-9.5
Profit / Loss for the Year
-14.2
-9.1
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.